Results 31 to 40 of about 335,217 (205)
A description of skeletal manifestation in adult case of morquio syndrome: radiographic and MRI appearance. [PDF]
We report on a rare case of Morquio syndrome, an autosomal recessive mucopolysaccharidosis including type IVA, a deficiency of N-acetylgalctosamine-6-sulfatase and type IVB a deficiency of β-galactosidase.
Di Cesare A +5 more
europepmc +2 more sources
Morquio syndrome (MPV IV)-A case report
A child, of normal intelligence, belonging to a nonconsanguineous marriage was diagnosed as MPS type IV the so called Morquio syndrome. Despite mild corneal cloudiness no other ophthalmological abnormalities were observed.
Rekhi Gulbir
doaj +2 more sources
Phenotype-Genotype Correlation in Morquio A Syndrome: Protocol for a Meta-Analysis.
BackgroundMucopolysaccharidosis type IVA (MPS IVA), also known as Morquio A syndrome, is a rare lysosomal storage disease characterized by autosomal recessive inheritance of mutations in the N-acetylgalactosamine-6-sulfatase ...
Diaz-Ordoñez L +5 more
europepmc +2 more sources
Overcoming the barriers to diagnosis of Morquio A syndrome [PDF]
Morquio A syndrome is an autosomal recessive lysosomal storage disease often resulting in life-threatening complications. Early recognition and proficient diagnosis is imperative to facilitate prompt treatment and prevention of clinical complications.Experts in Asia Pacific reviewed medical records focusing on presenting signs and symptoms leading to a
Adeline Tan +20 more
core +4 more sources
Characterization of a novel exonic deletion in the GALNS gene causing Morquio A syndrome
Mucopolysaccharidosis IVA or Morquio A syndrome is a rare lysosomal storage disorder caused by N-acetylgalactosamine-6-sulfatase deficiency. A diagnosis can be provided by the identification of reduced N-acetylgalactosamine-6-sulfatase activity as well ...
Kathryn DeLong +4 more
doaj +1 more source
Therapies of mucopolysaccharidosis IVA (Morquio A syndrome) [PDF]
Morquio A syndrome (mucopolysaccharidosis type IVA, MPS IVA) is one of the lysosomal storage diseases and is caused by the deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS). Deficiency of this enzyme leads to accumulation of glycosaminoglycans (GAGs), keratan sulfate (KS) and chondroitin-6-sulfate (C6S).
Shunji, Tomatsu +11 more
openaire +2 more sources
Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management. [PDF]
Mucopolysaccharidosis type IVA (MPS IVA, or Morquio syndrome type A) is an inherited metabolic lysosomal disease caused by the deficiency of the N-acetylglucosamine-6-sulfate sulfatase enzyme.
Couce, Maria L. +6 more
core +2 more sources
Activity of daily living for Morquio A syndrome [PDF]
The aim of this study was to evaluate the activity of daily living (ADL) and surgical interventions in patients with mucopolysaccharidosis IVA (MPS IVA). The factor(s) that affect ADL are age, clinical phenotypes, surgical interventions, therapeutic effect, and body mass index.
Eriko, Yasuda +24 more
openaire +2 more sources
Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia
We identified differences in cytokine expression in multiple types of pediatric skeletal dysplasia as compared to typically growing children. Four of the 12 analyzed cytokines demonstrated elevated expression above control levels in all of the dysplasia cohorts (IL‐12, IL‐13, IP‐10, RANTES) and 2 demonstrated expression below control levels across all ...
David A. O'Connell +6 more
wiley +1 more source
Modeling Morquio A Syndrome: An Anthropometric Study of Body Characteristics and Stature
Background: Morquio A syndrome or mucopolysaccharidosis (MPS) IVA is an autosomal recessive, life-limiting lysosomal storage disease caused by deficient activity of the enzyme galactosamine-6-sulfatase. Common early symptoms such as abnormalities of body
Agnieszka Różdżyńska-Świątkowska +3 more
doaj +1 more source

